MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.

Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors

C Dettbarn, S Gyorke and P Palade

Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston 77555-0641.

Ryanodine receptors have recently been shown to undergo an unusual kind of inactivation process termed adaptation, which bears similarities to the transient calcium releases induced in other systems by successive incremental additions of inositol-1,4,5-trisphosphate. Such releases are sometimes termed "quantal". In this study we report that many agonists induce similar behavior in muscle sarcoplasmic reticulum and that the responses depend not on the calcium pumps therein but rather on the ryanodine receptors. The chemical diversity of these agonists makes it very unlikely that adaptation simply affects the sensitivity of the receptor to agonists at any one binding site. More likely, this result indicates that adaptive behavior of ryanodine receptors results whenever the ryanodine receptor is activated and that this process affects the action of most, if not all, agonists. Evidence is presented suggesting that the releases observed do not represent all-or-none releases from vesicle subpopulations (true quantal behavior) but rather seem to involve partial release from more homogeneously sensitive stores, a process referred to here as adaptation or increment detection.

Volume 46, Issue 3, pp. 502-507, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
R. Kawai, T. Horikoshi, and M. Sakakibara
Involvement of the Ryanodine Receptor in Morphologic Modification of Hermissenda Type B Photoreceptors After In Vitro Conditioning
J Neurophysiol, February 1, 2004; 91(2): 728 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lloyd-Evans, D. Pelled, C. Riebeling, J. Bodennec, A. de-Morgan, H. Waller, R. Schiffmann, and A. H. Futerman
Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms
J. Biol. Chem., June 20, 2003; 278(26): 23594 - 23599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Koizumi, P. Lipp, M. J. Berridge, and M. D. Bootman
Regulation of Ryanodine Receptor Opening by Lumenal Ca2+ Underlies Quantal Ca2+ Release in PC12 Cells
J. Biol. Chem., November 19, 1999; 274(47): 33327 - 33333.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Dettbarn and P. Palade
Effects of Three Sarcoplasmic/Endoplasmic Reticulum Ca++ Pump Inhibitors on Release Channels of Intracellular Stores
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 739 - 745.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Dettbarn and P. Palade
Ca2+ Feedback on "Quantal" Ca2+ Release Involving Ryanodine Receptors
Mol. Pharmacol., December 1, 1997; 52(6): 1124 - 1130.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics